Department of eyeSmart EMR and AEye; Indian Health Outcomes, Public Health and Economics Research Center, L V Prasad Eye Institute, Telangana, India.
Cornea Service, The Cornea Institute, L V Prasad Eye Institute; Ramayamma International Eye Bank, The Cornea Institute, LV Prasad Eye Institute, Telangana, India.
Indian J Ophthalmol. 2021 Dec;69(12):3658-3662. doi: 10.4103/ijo.IJO_1740_21.
To describe the impact of lockdown and unlock phases of the COVID-19 pandemic on keratoplasty trends at a tertiary eye care center in India.
This cross-sectional hospital-based study included 6,277 patients presenting between March 25, 2017 and March 31, 2021. The data of the patients who underwent keratoplasty during the lockdown and unlock phases were compared with the respective periods in the previous three years before COVID-19.
During the year one of pandemic, there was a 29.46% decline in the total number of keratoplasty performed at the institute compared to previous year's annual numbers. The patients undergoing keratoplasty decreased by 90.28% (28/288) of pre-COVID-19 volumes during the lockdown phase. This was mainly because of a 40.6% reduction in the proportion of patients requiring interstate travel. There was complete recovery in the number of patients undergoing keratoplasty to 129.27% (184/142) of pre-COVID-19 volumes by March 2021. This gradual incremental trend was seen across all types of keratoplasty in Descemet stripping endothelial keratoplasty (135.29%), penetrating keratoplasty (117.6%), therapeutic keratoplasty (122.22%), anterior lamellar keratoplasty (150%), and Descemet membrane endothelial keratoplasty (141.18%) by March 2021 with the gradual ease of lockdown regulations. The eye bank affiliated to the institute saw a 55.44% decline in donor cornea collection and an increase in utilization rate from 58.12% in previous years to 83.78% in year one of the pandemic. The overall eye bank donor cornea collection recovered to 86.96% (627/721) and tissue utilization increased by 109.99% (455/414) by March 2021.
The first year of the COVID-19 pandemic saw an overall reduction of 29.46% of the patients undergoing keratoplasty at the institute. There was a gradual and incremental increase in all types of keratoplasty in the unlock phase, which surpassed the preceding years' monthly numbers in February and March.
描述 COVID-19 大流行的封锁和解锁阶段对印度一家三级眼科护理中心角膜移植趋势的影响。
这是一项基于医院的横断面研究,纳入了 2017 年 3 月 25 日至 2021 年 3 月 31 日期间就诊的 6277 名患者。将封锁和解锁阶段接受角膜移植的患者数据与 COVID-19 前三年同期进行比较。
在大流行的第一年,与前一年的年度数量相比,该机构进行的角膜移植总数下降了 29.46%。在封锁期间,接受角膜移植的患者数量下降了 90.28%(28/288),降至 COVID-19 前的水平。这主要是因为需要州际旅行的患者比例减少了 40.6%。到 2021 年 3 月,接受角膜移植的患者数量完全恢复到 COVID-19 前的 129.27%(184/142)。在逐步放宽封锁规定的情况下,所有类型的角膜移植都呈现出这种逐渐递增的趋势,包括 Descemet 剥离内皮角膜移植术(135.29%)、穿透性角膜移植术(117.6%)、治疗性角膜移植术(122.22%)、前板层角膜移植术(150%)和 Descemet 膜内皮角膜移植术(141.18%)。该机构所属的眼库供体角膜采集量下降了 55.44%,利用率从前几年的 58.12%上升至大流行第一年的 83.78%。到 2021 年 3 月,眼库供体角膜采集总量恢复到 86.96%(627/721),组织利用率增加了 109.99%(455/414)。
COVID-19 大流行的第一年,该机构接受角膜移植的患者总数下降了 29.46%。在解锁阶段,各种类型的角膜移植都呈现出逐渐递增的趋势,2 月和 3 月的每月数量超过了前几年的水平。